MK

Marko Kreft

Technical Director, PhD, Professor

Celica Biomedical

Therapeutic Areas

Celica Biomedical Pipeline

DrugIndicationPhase
Astrocyte-targeted CNS TherapiesCNS Trauma, Neurodegenerative Diseases, Brain Edema, GliomaDiscovery/Pre-clinical
Dendritic Cell-Based Cancer VaccinesCancer (unspecified)Pre-clinical